|
655 Further
DoH guidance provides clarification on PBC Further guidance on the implementation of practice-based commissioning (PBC) is published by the Department of Health this week. The guidance supersedes “Practice-based commissioning: achieving universal coverage”, published in January
PJ 2006;277:655
Full Text
655 Evidence of
benefits needed if pharmacists want to succeed in PBC Good
evidence of the benefits of pharmacy-based services will be essential
if pharmacists are to wrest control of practice-based commissioning from
GPs, the All-Party Pharmacy Group's inquiry into the future of pharmacy
heard this week
PJ 2006;277:655
Full Text
655 Extending CD prescribing
poses no risk There are no safety concerns with allowing pharmacist
and nurse independent prescribers to prescribe Controlled Drugs, the Commission
on Human Medicines has decided
PJ 2006;277:655
Full Text
655 Pharmacists recruited
to fight terrorism Pharmacies, and other high street retailers, have
been asked to be alert to the possibility that some products they sell could
be used by terrorists
PJ 2006;277:655
Full Text
656 Views
sought on code for promoting NHS services Whether pharmacists should be included under a new “Code of practice for promotion of NHS services” is one of the points raised in a consultation document on the proposed code, published by the Department of Health this week
PJ 2006;277:656
Full Text
656 Pharmacy patient satisfaction
surveys soon Patients may soon be asked how well they think community
pharmacies are delivering NHS pharmaceutical services
PJ 2006;277:656
Full Text
656 Health and social
care regulation to merge Plans to merge the Healthcare Commission
and the Commission for Social Care Inspection have been put out for public consultation
by the Department of Health. The new inspectorate will also take over the role
of the Mental Health Act Commission
PJ 2006;277:656
Full Text
656 PSNC suggests pharmacies
should consider chaperones Community pharmacies offering services
that involve physical contact with patients, or consultations in private consultation
areas, should consider having a chaperone policy in place, according to the Pharmaceutical
Services Negotiating Committee
PJ 2006;277:656
Full Text
657 Consultation
begins on the future structure of PECs Consultation on a review of primary care trust (PCT) professional executive committees (PECs) in England began last week when the NHS Alliance, on behalf of the Department of Health, published “Fit to lead”, a review of PECs informed by the opinions and experiences of key stakeholders, including pharmacists
PJ 2006;277:657
Full Text
657 Government consults
on stoma appliances Proposals to change the reimbursement prices for
stoma and incontinence appliances and the terms of service under which they are
supplied have been set out in two consultations published by the Department of
Health this week
PJ 2006;277:657
Full Text
657 CPP proposes a royal
college for professional leadership The College of Pharmacy Practice
has proposed the creation of a royal college of pharmacy to absorb the professional
leadership functions of the Royal Pharmaceutical Society
PJ 2006;277:657
Full Text
657 Foster review ignores
non-NHS professionals, says IPMI Recent regulatory proposals from
the Department of Health seem to apply only to health professionals who work
in the NHS, the Institute of Pharmacy Management International has said. The
consequences for professionals who do not work with patients have not been considered
PJ 2006;277:657
Full Text
658 Vigorous
education vs training debate expected Robust discussion of the relationship
between education and training has been forecast by the heads of schools of pharmacy
PJ 2006;277:658
Full Text
658 Alliance Boots takes
action against GIRP The wholesale and commercial affairs division of Alliance Boots plc has begun legal proceedings in Belgium to review the actions of the European Association of Pharmaceutical Full-line Wholesalers (GIRP) in relation to Pfizer and UniChem’s “Direct to pharmacy” (DTP) distribution agreement in the UK
PJ 2006;277:658
Full Text
658 ABPI sees clinical
trial opportunity in CfH records Electronic patient records could
be used to help recruit clinical trial volunteers, according to Richard Barker,
director general of the Association of the British Pharmaceutical Industry
PJ 2006;277:658
Full Text
658 Do not send originals
of CD prescriptions to NHS pricing offices yet, PSNC warns Pharmacy
contractors should continue to send copies of private prescriptions for Schedule
2 and 3 Controlled Drugs to the NHS Business Services Authority and keep the
original forms for their own records, despite information to the contrary in
Part XX of the Drug Tariff, the Pharmaceutical Services Negotiating Committee
said last week
PJ 2006;277:658
Full Text
658 Audit committee scrutinises NHS Wales’s finances Consideration of changes to the monitoring of the financial performance of local health boards has been recommended by the Welsh national assembly’s audit committee
PJ 2006;277:658
Full Text
659 HAART
adherence barriers similar across settings and countries Barriers
to adherence to highly active antiretroviral therapy (HAART) are largely consistent
across multiple settings and countries, a recent study suggests
PJ 2006;277:659
Full Text
659 Clear evidence against
episodic HIV treatment HIV-infected patients are at increased risk
of opportunistic disease or death if they are treated using a strategy of episodic
antiretroviral therapy guided by their CD4+ count, rather than given continuous
antiretroviral therapy, say researchers
PJ 2006;277:659
Full Text
659 63,500 HIV cases in
UK An estimated 63,500 adults are living with HIV in the UK, according
to the Health Protection Agency. The figure includes individuals who have received
a diagnosis and just over 20,000 who the HPA estimates to be unaware of their
condition
PJ 2006;277:659
Full Text
659 Varenicline launch
next week Smokers may be able to kick the habit with the help of a
new medicine, available in the UK next week from Pfizer
PJ 2006;277:659
Full Text
659 New CML treatment
available A new treatment for chronic myeloid leukaemia (CML) has
been launched by Bristol-Myers Squibb
PJ 2006;277:659
Full Text
660 Antibiotics
more beneficial in bilateral otitis media Antibiotics are beneficial
for relieving pain and fever in children aged under two years with acute otitis
media in both ears or for children of any age with acute otitis media and otorrhoea
(discharge from the ear), the authors of a study published conclude
PJ 2006;277:660
Full Text
660 Full correction of
anaemia in CRF poses risks Correction of haemoglobin levels to within the normal range (13–15g/dL; known as full correction) with epoetin does not improve cardiovascular outcomes for patients with chronic renal failure, two studies published have shown
PJ 2006;277:660
Full Text
660 Chloramphenicol eye
ointment Three companies (Aventis Pharma Ltd, Optrex Ltd and Galpharm
International Ltd) have applied to the Medicines and Healthcare products Regulatory
Agency for their chloramphenicol 1 per cent eye ointment products to be classified
as pharmacy medicines
PJ 2006;277:660
Full Text
660 GSL application for
cetirizine Galpharm Healthcare Ltd has applied to the Medicines and
Healthcare products Regulatory Agency for Galpharm Hayfever and Allergy Relief
(cetirizine 10mg tablets) to be added to the general sales list
PJ 2006;277:660
Full Text
661 Heart
failure project likely to be recognised as enhanced service An award
winning community pharmacy heart failure medicines service in Scotland is on
track to receive funding to continue as a locally enhanced service
PJ 2006;277:661
Full Text
661 Bivalirudin reduces
bleeding risk compared with standard therapy in coronory syndromes Use
of bivalirudin to treat acute coronary syndromes is as effective as standard
drugs but reduces the risk of major bleeding, a study published last week suggests
PJ 2006;277:661
Full Text
661 Statins used for CV
primary prevention reduce morbidity Use of statins for people without
cardiovascular disease (primary prevention) offers a reduction in major coronary
and cerebrovascular events, researchers have found. But their meta-analysis failed
to reveal a reduction in mortality
PJ 2006;277:661
Full Text
661 DTB moves to BMJ Group The
Drug and Therapeutics Bulletin has been acquired by the BMJ Group
PJ 2006;277:661
Full Text
661 Fresh start for Healthy
Start Healthy Start, launched in Devon and Cornwall last year, went
UK-wide last weekend
PJ 2006;277:661
Full Text
661 Welsh smoking ban
progress Final draft Regulations to enable enforcement of the smoking ban in enclosed public spaces in Wales were published last week and will now be scrutinised by the Welsh Assembly Government’s Health and Social Services Committee
PJ 2006;277:661
Full Text
|
The
Pharmaceutical Journal